APP and Alzheimer disease: While APP/PS1 mice and Aβ25-35 treated neurons presented increased Grp78 expression (reviewed in Reference [100]), another study in AD post-mortem brains with PS1 mutations showed a reduction in Grp78 mRNA levels [101].